Trials / Completed
CompletedNCT03831763
Evaluation of the Use of Various Assessments of Common Cold Symptoms for Proof of Efficacy of ColdZyme Mouth Spray
Single (Investigator)-Blind, Randomized, Parallel-group Study to Evaluate the Use of Various Assessments of Common Cold Symptoms for Proof of Efficacy of CMS016317
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (actual)
- Sponsor
- Enzymatica AB · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the use of various assessments of common cold symptoms for proof of efficacy of ColdZyme Mouth Spray on naturally acquired common colds. Half of the participants will receive ColdZyme® Mouth Spray while the other half may use optional care as needed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ColdZyme | ColdZyme® Mouth Spray is a CE-marked medical device with the following composition: glycerol, water, cod trypsin, ethanol (\<1 %), calcium chloride, trometamol and menthol. ColdZyme® Mouth Spray consists of a 20 ml bottle, pump, spray nozzle and protective cap. |
Timeline
- Start date
- 2018-01-25
- Primary completion
- 2018-06-05
- Completion
- 2018-06-05
- First posted
- 2019-02-06
- Last updated
- 2019-08-21
Locations
7 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03831763. Inclusion in this directory is not an endorsement.